Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Family Physician
MBBS, MCPS (Family Medicine)
Internal Medicine Specialist
MBBS, MCPS Family Medicine
General Physician
MBBS, MCPS (Family Medicine)
General Physician
MBBS, FCPS (Gastroentrology)
Internal Medicine Specialist
B.Sc, M.B.B.S, M.D Internal Medicine, Certification in Medical Teaching
Internal Medicine Specialist
B.Sc, M.B.B.S, M.D Internal Medicine, Certification in Medical Teaching
Diabetologist
MBBS, MPH, Certification Course in Diabetology (UK), Diploma in Diabetology & Endocrinology
Diabetologist
MBBS, MPH, Certification Course in Diabetology (UK), Diploma in Diabetology & Endocrinology
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures